Pharmacogenetics of antidepressant response: A polygenic approach
Discussion We identified no significant predictive effect using PRS between pharmacogenetic studies. The genetic liability to MDD or schizophrenia did not predict response to antidepressants, suggesting differences between the genetic component of depression and treatment response. Larger or more homogeneous studies will be necessary to obtain a polygenic predictor of antidepressant response.
Source: Progress in Neuro Psychopharmacology and Biological Psychiatry - Category: Psychiatry Source Type: research
More News: Celexa | Citalopram | Depression | Genetics | Lexapro | Neurology | Psychiatry | Schizophrenia | Statistics | Study